UCB Files Patent Infringement Lawsuit vs. Actavis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 3:40PM CDT
Actavis has filed an ANDA with the FDA seeking marketing approval for its generic version of UCB's Neupro. In response, UCB filed a lawsuit against Actavis.
Zacks.com featured expert Kevin Matras highlights: Multi-Color, Silicon Motion Technology, ICON plc., Akorn, Inc. and Sealed Air Corp.
PR Newswire - Thu Aug 28, 8:30AM CDT
Stocks in this week's article include: Multi-Color (NASDAQ: LABL - Free Report), Silicon Motion Technology (NASDAQ: SIMO - Free Report), ICON plc. (NASDAQ: ICLR - Free Report), Akorn, Inc. (NASDAQ: AKRX - Free Report) and Sealed Air Corp. (NYSE: SEE - Free Report). Small-cap stocks are often market leaders, but don't overlook the mid-caps and large-caps. See how that leadership has changed over the years and which one is in the lead now.
Stocks Rise As Biotechs Lead; Amazon To Buy Twitch
at Investor's Business Daily - Tue Aug 26, 3:58PM CDT
Stocks were moderately higher Monday with biotech stocks leading the way. The Nasdaq and the Dow Jones industrial average rose 0.4% and the S&P 500 gained 0.5%. After the close, Amazon (AMZN) announced it was paying $970 million to buy Twitch, a live...
Market-Caps and Stock Selection for Maximum Gains - Screen of the Week
Kevin Matras - ZACKS - Tue Aug 26, 3:11AM CDT
Market-Caps and Stock Selection for Maximum Gains - Screen of the Week
Stocks Higher With Biotechs Leading The Way
at Investor's Business Daily - Mon Aug 25, 3:34PM CDT
The stock market was moderately higher Monday, with the S&P 500 topping 2000 intraday for the first time. Biotechs led the way on the strength of a major takeover. The Nasdaq and Dow industrials rose 0.4% each; the S&P 500 gained 0.5%. Nasdaq volume...
Main Indexes Slip From Highs; Biotechs Show Strength
at Investor's Business Daily - Mon Aug 25, 12:27PM CDT
Stocks backed off session highs Monday, but were still nicely higher in early afternoon trading. The S&P 500 and Dow Jones industrial average each rose 0.4%. while the Nasdaq added 0.2%. Gains for the S&P 500 and Nasdaq hit 0.7% intraday. Turnover...
Akorn Up 53.1% Since SmarTrend Uptrend Call (AKRX)
Comtex SmarTrend(R) - Fri Aug 22, 10:59AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 4 months, Akorn has returned 53.08% as of today's recent price of $37.58.
Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 3:30PM CDT
Actavis plc's (ACT) shares were up 2.3% with the company announcing positive top-line results from the phase III RECLAIM-1 and -2 studies on ceftazidime-avibactam.
Akorn Larger Than S&P 500 Component Rowan Companies
TheOnlineInvestor.com - Wed Aug 20, 3:41PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Akorn Inc was identified as having a larger market cap than the smaller end of the S&P 500, for example Rowan Companies plc , according to The Online...
Should You Get Rid of Corium International (CORI) Now? - Tale of the Tape
Zacks Research Stuff - Zacks Investment Research - Wed Aug 20, 7:55AM CDT
Corium International stock could bring additional losses for your portfolio
Mallinckrodt Acquires Questcor, to Join S&P 500 As Well - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 3:30PM CDT
Mallinckrodt announced the completion of its acquisition of Questcor Pharmaceuticals, Inc. in a deal valued at approximately $5.8 billion.
Supernus's SPN-810 Gets Fast Track Status for ADHD - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 12:30PM CDT
Supernus Pharmaceuticals, Inc.'s (SUPN) attention deficit hyperactivity disorder (ADHD) candidate, SPN-810 has received Fast track status in the U.S.
Stock Futures Steer Higher; Dollar General, Akorn Rising
at Investor's Business Daily - Mon Aug 18, 8:04AM CDT
Stock futures were up and holding near early highs ahead of Monday's open, boosted by rallying European markets. Dow futures traded ahead 87.1 points. Nasdaq 100 futures were 20.3 points above fair market value. S&P 500 futures rose 10.7 points, and...
Akorn Has Returned 47.5% Since SmarTrend Recommendation (AKRX)
Comtex SmarTrend(R) - Fri Aug 15, 9:40AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 4 months, Akorn has returned 47.54% as of today's recent price of $36.22.
Perrigo Beats on Q4 Earnings and Sales, Provides Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 12:29PM CDT
Perrigo (PRGO) reported higher than expected earnings and revenues in the fourth quarter.
Akorn,Dean Foods, IMAX, Walt DisneyandLions Gate Entertainmenthighlighted as Zacks Bull and Bear of the Day
PR Newswire - Thu Aug 14, 8:30AM CDT
Zacks Equity Research highlights Akorn Inc (Nasdaq:AKRX-Free Report) as the Bull of the Day and Dean Foods Corp (NYSE
Cerulean Pharma (CERU) Worth Watching: Stock Soars 30.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 8:25AM CDT
Cerulean Pharma (CERU) was a big mover last session, with shares surging nearly 31% on the day.
Mallinckrodt Beats on Q3 Earnings and Revenues, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 12:23PM CDT
Shares of Mallinckrodt plc (MNK) gained 0.46% following the company's third quarter fiscal 2014 (ended Jun 27, 2014) earnings report last week.